Though the positive correlation between high STMN1 expression and poor prognosis of GC and CRC patients is not as apparently as that in LIHC, there is a trend that GC or CRC patients bearing highly STMN1-expressed tumor have poor prognosis (Supplementary Fig. S5). The gene discussed is STMN1; the disease is neoplasm.